graphic illustration of circles linked by lines.

Publications

The following scientific publications have been supported by the outputs of the PRESTIGE-AF consortium:

Olma, M.C. et al, “In‐Hospital ECG Findings, Changes in Medical Management, and Cardiovascular Outcomes in Patients With Acute Stroke or Transient Ischemic Attack”, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023, 12,
View
Ingwerson, T. et al, “Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source”, Neurological Research and Practice, 2023, 5,
View
Olma, M.C. et al, “Extent of routine diagnostic cardiac work-up at certified German stroke units participating in the prospective MonDAFIS study”, Neurological Research and Practice, 2023,
View
Lucio D’Anna, Graham Searle, Kirsten Harvey, Paul M. Matthews & Roland Veltkamp, “Time course of neuroinflammation after human stroke – a pilot study using co-registered PET and MRI”, BMC Neurology, 2023,
View
Ivany, E. et al, “Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis”, Stroke, 2022, 53,
View
Duperron, M.G. et al, “Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease”, Nature Medicine, 2023, 29,
View
Crespo Pimental, B. et al, “Association of stroke lesion shape with newly detected atrial fibrillation – Results from the MonDAFIS study”, European Stroke Journal, 2022, 7,
View
Stéphanie Debette and Hugh S. Markus, “Stroke Genetics: Discovery, Insight Into Mechanisms, and Clinical Perspectives”, Circulation Research, 2022, 130,
View
Mishra, A. et al, “Stroke genetics informs drug discovery and risk prediction across ancestries”, Nature, 2022,
View
Al-Shahi Salman, R. et al, “Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials”, The Lancet Neurology, 2023, 22,
View
Elena Ivany, Robyn R Lotto, Gregory Y H Lip, Deirdre A Lane, “Managing Uncertainty: Physicians' Decision Making for Stroke Prevention for Patients with Atrial Fibrillation and Intracerebral Hemorrhage”, Thrombosis and Haemostasis, 2022, 122,
View
Foerster, K.I., Hermann, S., Mikus, G. et al., “Drug–Drug Interactions with Direct Oral Anticoagulants”, Clin Pharmacokinet, 2020, vol 59,
View
Wafa, H.A., Wolfe, C.D.A., Emmett, E., Roth, G.A., Johnson, C.O., Wang, Y., “Burden of Stroke in Europe. Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years”, Stroke, 2020, vol 51,
View
D'Anna, L., Filippidis, F.T., Antony, S., Brown, Z., Wyatt, H., Malik, A., Sivakumaran, P., Harvey, K., Marinescu, M., Bentley, P., Korompoki, E., & Veltkamp, R., “Early initiation of direct anticoagulation after stroke in patients with atrial fibrillation”, European Journal of Neurology, 2020, vol 27, iss 11,
View
Elkind, M.S.V., Veltkamp, R., Montaner, J., Johnston, S.C., Singhal, A.B., Becker, K., Lansberg,M.G.,Tang, W., Kasliwal, R., & Elkins, J., “Natalizumab in acute ischemic stroke (ACTION II) A randomized, placebo-controlled trial”, Neurology, 2020, 95, iss 8,
View
Sargurupremraj, M., Suzuki, H., Jian, X. et al, “Cerebral small vessel disease genomics and its implications across the lifespan”, Nature communications, 2020, 11:6285,
View
Wardlaw, J.M., Debette, S., Jokinen, H. et al, “ESO Guideline on covert cerebral small vessel disease”, European Stroke Journal, 2021, 6:2,
View
Veltkamp, R., Purrucker, J.C., Weber, R. et al, “Neurovascular manifestations of COVID‑19”, Der Nervenarzt, 2021, 92,
View
D'Anna, L., Filippidis, F.T., Harvey, K. et al, “Extent of white matter lesion is associated with early hemorrhagic transformation in acute ischemic stroke related to atrial fibrillation”, Brain and behaviour, 2021, 11:8,
View
Nielsen, P.B., Melgaard, L., Overvad, T.F. et al, “Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study”, Stroke, 2022, 0:10,
View
Le Grand, Q., Satizabal, C.L., Sargurupremraj, M. et al, “Genomic Studies Across the Lifespan Point to Early Mechanisms Determining Subcortical Volumes”, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2022, 7:6,
View
Mishra, A., Duplaà, C., Vojinovic, D. et al, “Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate”, Brain, 2022, 145:6,
View
Bordes, C., Sargurupremraj, M., Mishra, A. & Debette, S, “Genetics of common cerebral small vessel disease”, Nature reviews neurology, 2022, 18,
View